Botanical-Based Anti-Viral Therapies
Ancient medicine, Modern science
Why Aviratek?
Aviratek Biomedical Solutions, LLC has intellectual properties and a recently-issued patent surrounding the preparation and use of certain plants, plant blends, phytochemicals, and phytochemical semi-synthetic derivatives that have been shown scientifically to be active against various strains and sub-strains of herpesvirus in vitro.
Potential FDA-Approved Therapeutic Applications: Herpes
Cold Sores
70%
Of Adults in the U.S. are infected
Shingles
1 in 3
Americans will become infected
Epstein-Barr
90%
Of Adults in the U.S. are infected
Genital Herpes
50 Million
Of Adults in the U.S. are infected
Treatment for diseases including:
-
Herpes viruses (including herpes simplex-1 ‘cold sores’, herpes simplex-2 ‘genital herpes’, and varicella-zoster ‘shingles’)
-
Papilloma viruses (including those associated with cervical cancer and dysplasia, actinic keratosis, squamous cell carcinoma, genital warts, and common/plantar warts)
-
Poxviruses (including emerging monkeypox, molluscum contagiosum and the significant bioterror threat of smallpox)
Our goals are to:
-
Identify, test and screen worldwide botanicals for anti-viral and anti-cancer activity
-
Characterize the activity and identify the mechanism of action of these botanicals for anti-viral and anti-cancer activity
-
Perform standardization and quality control of all botanical extracts
-
Isolate and identify active constituent(s)
-
Design, implement and analyze clinical studies
"THIS DISCOVERY IS TO VIRUSES
AS PENICILLIN IS TO BACTERIA"
-DR. RICHARD CHAMBERLAIN
Biodesign Institute Building A, 1001 S McAllister Ave, Tempe, AZ 85281